What is the ticker symbol for Telomir Pharmaceuticals?

Telomir Pharmaceuticals trades under the ticker TELO on NASDAQ.

What sector does Telomir Pharmaceuticals operate in?

Telomir Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TELO in a portfolio?

PortView shows TELO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Telomir Pharmaceuticals (TELO) Stock Analysis

NASDAQHealthcareBiotechnology

$1.13+2.27%

1-year price historyRange $0.92 – $1.93

52-week range$1.13

$0.89$2.09

What Telomir Pharmaceuticals does

Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions. Its primary focus involves the development of TELOMIR-1, an innovative small molecule compound. This oral medication is being engineered to serve as a therapeutic solution against various age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, and also to assist in recovery post-chemotherapy. It achieves this by disrupting and inhibiting inflammatory pathways that are triggered by interleukin-17. Established in 2021, the company was initially known as Metallo Therapies Inc., officially adopting the name Telomir Pharmaceuticals, Inc. on October 10, 2022. The company's headquarters are located in Baltimore, Maryland.

Key metrics

Market cap

$77.37M

P/E (TTM)

-3.88

EPS (TTM)

$-0.29

Beta

-0.24

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.18

200-day avg

$1.28

52-week high

$2.09

52-week low

$0.89

CEO

Erez Aminov

ETFs linked to TELO

Broad-market and Healthcare sector ETFs an investor holding Telomir Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TELO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TELO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Telomir Pharmaceuticals?: Telomir Pharmaceuticals trades under the ticker TELO on NASDAQ.
Which exchange is TELO listed on?: TELO is listed on NASDAQ.
What sector does Telomir Pharmaceuticals operate in?: Telomir Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TELO in a portfolio?: PortView shows TELO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.